US Patent Family Members and Approved Drugs for European Patent Office Patent: 2332565
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: EP2332565
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2027-07-24 | adalimumab | Abbvie Inc. | HUMIRA |
| ⤷ Get Started Free | 2026-05-16 | adalimumab | Abbvie Inc. | HUMIRA |
| ⤷ Get Started Free | 2027-09-10 | adalimumab | Abbvie Inc. | HUMIRA |
| ⤷ Get Started Free | 2023-07-18 | adalimumab | Abbvie Inc. | HUMIRA |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
